Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tine van de Donk

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Opinion in Supportive and Palliative Care|March 18, 2017
Ketamine for cancer pain: what is the evidence?Kelly Jonkman, Tine van de Donk, Albert Dahan
European Journal of Pain (London, England)|June 5, 2019
Cornea nerve fibre state determines analgesic response to tapentadol in fibromyalgia patients without effective endogenous pain modulationTine van de Donk, Monique van Velzen, Albert Dahan, et al.
F1000Research|October 6, 2017
Ketamine for painKelly Jonkman, Albert Dahan, Tine van de Donk, et al.
Pain|December 27, 2018
An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgiaTine van de Donk, Marieke Niesters, Mikael A Kowal, et al.
BMJ Open Gastroenterology|August 4, 2016
The first cases of collagenous sprue successfully treated with thioguanineTom van Gils, Tine van de Donk, Gerd Bouma, et al.
Pain Reports|December 28, 2020
Tapentadol treatment results in long-term pain relief in patients with chronic low back pain and associates with reduced segmental sensitizationTine van de Donk, Jurjan van Cosburgh, Tom van Dasselaar, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Opinion in Supportive and Palliative Care|March 18, 2017
Ketamine for cancer pain: what is the evidence?Kelly Jonkman, Tine van de Donk, Albert Dahan
European Journal of Pain (London, England)|June 5, 2019
Cornea nerve fibre state determines analgesic response to tapentadol in fibromyalgia patients without effective endogenous pain modulationTine van de Donk, Monique van Velzen, Albert Dahan, et al.
F1000Research|October 6, 2017
Ketamine for painKelly Jonkman, Albert Dahan, Tine van de Donk, et al.
Pain|December 27, 2018
An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgiaTine van de Donk, Marieke Niesters, Mikael A Kowal, et al.
BMJ Open Gastroenterology|August 4, 2016
The first cases of collagenous sprue successfully treated with thioguanineTom van Gils, Tine van de Donk, Gerd Bouma, et al.
Pain Reports|December 28, 2020
Tapentadol treatment results in long-term pain relief in patients with chronic low back pain and associates with reduced segmental sensitizationTine van de Donk, Jurjan van Cosburgh, Tom van Dasselaar, et al.
Pageof 1